Serveur d'exploration COVID et hydrochloroquine - Exploration (Accueil)

Index « Keywords » - entrée « Female (MeSH) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Feline Infectious Peritonitis (virology) < Female (MeSH) < Femoral Fractures (diagnosis)  Facettes :

List of bibliographic references indexed by Female (MeSH)

Number of relevant bibliographic references: 601.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000003 (2021) Joshuan J. Barboza [Pérou] ; Diego Chambergo-Michilot [Pérou] ; Mariana Velasquez-Sotomayor [Pérou] ; Christian Silva-Rengifo [Pérou] ; Carlos Diaz-Arocutipa [Pérou] ; Jose Caballero-Alvarado [Pérou] ; Franko O. Garcia-Solorzano [Pérou] ; Christoper A. Alarcon-Ruiz [Pérou] ; Leonardo Albitres-Flores [Pérou] ; German Malaga [Pérou] ; Patricia Schlagenhauf [Suisse] ; Alfonso J. Rodriguez-Morales [Colombie]Assessment and management of asymptomatic COVID-19 infection: A systematic review.
000013 (2021) Sujeet Jha [Inde] ; Nitish Batra [Inde] ; Samreen Siddiqui [Inde] ; Ashutosh Yadav [Inde] ; Archa Misra [Inde] ; Menka Loomba [Inde] ; Sumeet Sethi [Inde] ; Swati Waghdhare [Inde]HCQ prophylaxis in COVID-19 did not show any QTc prolongation in Healthcare workers.
000014 (2021) Julio Echarte-Morales [Espagne] ; Carlos Minguito-Carazo [Espagne] ; Samuel Del Castillo-García [Espagne] ; Javier Borrego-Rodríguez [Espagne] ; Miguel Rodríguez-Santamarta [Espagne] ; Enrique Sánchez-Mu Oz [Espagne] ; Rubén Bergel-García [Espagne] ; Clea González-Maniega [Espagne] ; Silvia Prieto-González [Espagne] ; Paula Menéndez-Suarez [Espagne] ; Elena Tundidor-Sanz [Espagne] ; Tomás Benito-González [Espagne] ; Felipe Fernández-Vázquez [Espagne]Effect of hydroxychloroquine, azithromycin and lopinavir/ritonavir on the QT corrected interval in patients with COVID-19.
000017 (2021) Atiya R. Faruqui [Inde] ; Denis Xavier [Inde] ; Sandhya K. Kamat [Inde] ; Sujith J. Chandy [Inde] ; Bikash Medhi [Inde] ; Raakhi K. Tripathi [Inde] ; Yashashri C. Shetty [Inde] ; John Michael Raj [Inde] ; Sandeep Kaushal [Inde] ; S. Balakrishnan [Inde] ; Shubham Atal [Inde] ; Santanu K. Tripathi [Inde] ; Dinesh K. Badyal [Inde] ; Harihar Dikshit [Inde] ; Sukalyan Saha Roy [Inde] ; Niyati Trivedi [Inde] ; Suparna Chatterjee [Inde] ; Chetna Desai [Inde] ; C D Tripathi [Inde] ; Nirmala N. Rege [Inde] ; Pooja Gupta [Inde] ; R. Raveendran [Inde] ; Rajni Kaul [Inde] ; Nilima A. Kshirsagar [Inde]Safety of hydroxychloroquine in healthcare workers for COVID-19 prophylaxis.
000021 (2021) Pierre Ekobena [Suisse] ; Anton Ivanyuk [Suisse] ; Françoise Livio [Suisse][Pharmacovigilance update].
000023 (2021) Consuelo Luna-Mu Oz [Pérou] ; Giuliana Reyes-Florian [Pérou] ; Martin Seminario-Aliaga [Pérou] ; Angie Stapleton-Herbozo [Pérou] ; Lucy E. Correa-L Pez [Pérou] ; Dante M. Qui Ones-Laveriano [Pérou][Pediatric inflammatory multisystem syndrome associated with COVID-19: A report of 10 cases in a Peruvian hospital].
000024 (2021) A L Myasnikov ; S A Berns ; P A Talyzin ; F I Ershov[Interferon gamma in the treatment of patients with moderate COVID-19].
000025 (2021) Francisco Tejada Cifuentes [Espagne] ; Ángeles Lloret Callejo [Espagne] ; María José Tirado Peláez [Espagne] ; Olga Rubio Pulido [Espagne] ; Marta Ruiz-Morote Arag N [Espagne] ; Rocío Fernández Urrusuno [Espagne] ; María Isabel Mu Oz Carreras [Espagne] ; María Isabel Méndez Esteban [Espagne] ; Victoria Maestre Sánchez [Espagne] ; Antonio García Bonilla [Espagne] ; José Manuel Paredero Dominguez [Espagne] ; Virginia Arroyo Pineda [Espagne] ; Esther Marco Tej N [Espagne] ; Gregorio Romero Candel [Espagne] ; Ana Isabel Fernández Marchante [Espagne] ; José Marco Del Rio [Espagne] ; Teresa Ortiz Martín [Espagne] ; Piedad L Pez Sánchez [Espagne][Incidence of COVID-19 in patients under chronic treatment with hydroxychloroquine].
000027 (2021) S. Ortonobes Roig [Espagne] ; N. Soler-Blanco ; I. Torrente Jiménez ; E. Van Den Eynde Otero ; M. Moreno-Ari O ; M. G Mez-Valent[Clinical and pharmacological data in COVID-19 hospitalized nonagenarian patients].
000028 (2021) X S Wang [République populaire de Chine] ; J H Cai [République populaire de Chine] ; M. Zeng [République populaire de Chine] ; H. Tian [République populaire de Chine] ; H L Chang [République populaire de Chine] ; Y L Ge [République populaire de Chine] ; J J Li [République populaire de Chine] ; Z Q Wei [République populaire de Chine] ; J S Wang [République populaire de Chine][Clinical analysis of liver chemistries in children and adolescent with 2019-nCoV infection].
000031 (2021) Hülya Gamze Çelik [Turquie] ; Iran Keske [Turquie] ; Ülker Ener [Turquie] ; Müge Tekba [Turquie] ; Mahir Kapmaz [Turquie] ; Krü Taylan Ahin [Turquie] ; Asl Özy Ld R M [Turquie] ; Saide Aytekin [Turquie] ; Vedat Aytekin [Turquie] ; Önder Ergönül [Turquie]Why we should be more careful using hydroxychloroquine in influenza season during COVID-19 pandemic?
000034 (2021) Ennio Giulio Favalli [Oman] ; Francesca Ingegnoli [Italie] ; Rolando Cimaz [Italie] ; Roberto Caporali [Italie]What is the true incidence of COVID-19 in patients with rheumatic diseases?
000039 (2021) Roland Duculan ; Deanna Jannat-Khah ; Bella Mehta ; Lisa A. Mandl ; Medha Barbhaiya ; Anne R. Bass ; Carol A. MancusoVariables Associated With Perceived Risk of Contracting SARS-CoV-2 Infection During the COVID-19 Pandemic Among Patients With Systemic Rheumatic Diseases.
000042 (2021) Amaya García-Fernández [Espagne] ; Pablo Ramos-Ruiz [Espagne] ; Alicia Ibá Ez-Criado [Espagne] ; Scar Moreno-Pérez [Espagne] ; Cristina Cambra-Poveda [Espagne] ; Juan Gabriel Martínez-Martínez [Espagne]Usefulness and safety of self-electrocardiographic monitoring during treatment with hydroxychloroquine and azithromycin in COVID-19 patients.
000043 (2021) Albert Prats-Uribe [Royaume-Uni] ; Anthony G. Sena [États-Unis, Pays-Bas] ; Lana Yin Hui Lai [Royaume-Uni] ; Waheed-Ul-Rahman Ahmed [Royaume-Uni] ; Heba Alghoul ; Osaid Alser [États-Unis] ; Thamir M. Alshammari [Arabie saoudite] ; Carlos Areia [Royaume-Uni] ; William Carter [États-Unis] ; Paula Casajust [Espagne] ; Dalia Dawoud [Égypte, Royaume-Uni] ; Asieh Golozar [États-Unis] ; Jitendra Jonnagaddala [Australie] ; Paras P. Mehta [États-Unis] ; Mengchun Gong [République populaire de Chine] ; Daniel R. Morales [Royaume-Uni, Danemark] ; Fredrik Nyberg [Suède] ; Jose D. Posada [États-Unis] ; Martina Recalde [Espagne] ; Elena Roel [Espagne] ; Karishma Shah [Royaume-Uni] ; Nigam H. Shah [États-Unis] ; Lisa M. Schilling [États-Unis] ; Vignesh Subbian [États-Unis] ; David Vizcaya [Espagne] ; Lin Zhang [République populaire de Chine, Australie] ; Ying Zhang [République populaire de Chine] ; Hong Zhu [République populaire de Chine] ; Li Liu [République populaire de Chine] ; Jaehyeong Cho [Corée du Sud] ; Kristine E. Lynch [États-Unis] ; Michael E. Matheny [États-Unis] ; Seng Chan You [Corée du Sud] ; Peter R. Rijnbeek [Pays-Bas] ; George Hripcsak [États-Unis] ; Jennifer Ce Lane [Royaume-Uni] ; Edward Burn [Royaume-Uni, Espagne] ; Christian Reich [États-Unis] ; Marc A. Suchard [États-Unis] ; Talita Duarte-Salles [Espagne] ; Kristin Kostka [États-Unis] ; Patrick B. Ryan [Slovénie, États-Unis] ; Daniel Prieto-Alhambra [Royaume-Uni]Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort study.
000046 (2021) Paulo Roberto Bignardi [Brésil] ; Carolina Santos Vengrus [Brésil] ; Bruno Matos Aquino [Brésil] ; Alcindo Cerci Neto [Brésil]Use of hydroxychloroquine and chloroquine in patients with COVID-19: a meta-analysis of randomized clinical trials.
000047 (2021) Juliana Cepelowicz Rajter [États-Unis] ; Michael S. Sherman [États-Unis] ; Naaz Fatteh [États-Unis] ; Fabio Vogel [États-Unis] ; Jamie Sacks [États-Unis] ; Jean-Jacques Rajter [États-Unis]Use of Ivermectin Is Associated With Lower Mortality in Hospitalized Patients With Coronavirus Disease 2019: The Ivermectin in COVID Nineteen Study.
000054 (2021) Iván J. Nú Ez-Gil [Espagne] ; Antonio Fernández-Ortiz [Espagne] ; Charbel Maroud Eid [Espagne] ; Jia Huang [République populaire de Chine] ; Rodolfo Romero [Espagne] ; Victor Manuel Becerra-Mu Oz [Espagne] ; Aitor Uribarri [Espagne] ; Gisela Feltes ; Daniela Trabatoni [Italie] ; Inmaculada Fernandez-Rozas [Espagne] ; Maria C. Viana-Llamas [Espagne] ; Martino Pepe ; Enrico Cerrato [Italie] ; Maurizio Bertaina [Italie] ; Thamar Capel Astrua [Espagne] ; Emilio Alfonso [Cuba] ; Alex F. Castro-Mejía ; Sergio Raposeiras-Roubin ; Fabrizio D'Ascenzo ; Carolina Espejo Paeres [Espagne] ; Jaime Signes-Costa [Espagne] ; Alfredo Bardaji ; Cristina Fernandez-Pérez [Espagne] ; Francisco Marin [Espagne] ; Oscar Fabregat-Andres [Espagne] ; Ibrahim Akin [Allemagne] ; Vicente Estrada [Espagne] ; Carlos Macaya [Espagne]Underlying heart diseases and acute COVID-19 outcomes.
000057 (2021) Nobuaki Mori [Japon] ; Mitsuya Katayama [Japon] ; Shigenari Nukaga [Japon]Triple therapy with hydroxychloroquine, azithromycin, and ciclesonide for COVID-19 pneumonia.
000060 (2021) Diana Laila Ramatillah [Indonésie] ; Suri Isnaini [Indonésie]Treatment profiles and clinical outcomes of COVID-19 patients at private hospital in Jakarta.
000062 (2021) Mohamed A. Taha [États-Unis, Égypte] ; Christian A. Hall [États-Unis] ; Colin J. Shortess [États-Unis] ; Richard F. Rathbone [États-Unis] ; Henry P. Barham [États-Unis]Treatment Protocol for COVID-19 Based on T2R Phenotype.
000064 (2021) Michael Marks [Royaume-Uni] ; Pere Millat-Martinez [Espagne] ; Dan Ouchi [Espagne] ; Chrissy H. Roberts [Royaume-Uni] ; Andrea Alemany [Espagne] ; Marc Corbacho-Monné [Espagne] ; Maria Ubals [Espagne] ; Aurelio Tobias [Espagne] ; Cristian Tebé [Espagne] ; Ester Ballana [Espagne] ; Quique Bassat [Espagne] ; Bàrbara Baro [Espagne] ; Martí Vall-Mayans [Espagne] ; Camila G-Beiras [Espagne] ; Nuria Prat [Espagne] ; Jordi Ara [Espagne] ; Bonaventura Clotet [Espagne] ; Oriol Mitjà [Papouasie-Nouvelle-Guinée]Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.
000069 (2021) Waqas Aslam [Oman] ; Carla R. Lamb [États-Unis] ; Nadia Ali [États-Unis]Torsades de pointes in SARS-CoV-2 (COVID-19) pneumonia: medicine reconciliation and careful monitoring of QTc interval may help prevent cardiac complications.
000087 (2021) Romain Lutaud [France] ; Dimiti Scronias [France] ; Jeremy Ward [France] ; Pierre Verger [France]The hydroxychloroquine debate: a therapeutic dilemma for general practitioners.
000091 (2021) Fatemeh Sadat Hosseini [Iran] ; Alireza Malektojari [Iran] ; Sara Ghazizadeh [Iran] ; Mehdi Hassaniazad [Iran] ; Parivash Davoodian [Iran] ; Habib Dadvand [Iran] ; Amin Reza Nikpoor [Iran] ; Sara Nikoofal-Sahlabadi [Iran] ; Sara Kahoori [Iran] ; Mojtaba Sepandi [Iran] ; Soheil Hassanipour [Iran] ; Mohammad Fathalipour [Iran]The efficacy and safety of Ivermectin in patients with mild and moderate COVID-19: A structured summary of a study protocol for a randomized controlled trial.
000095 (2021) Po-Liang Chen [République populaire de Chine] ; Yi-Han Hsiao [République populaire de Chine] ; Chien Chuang [République populaire de Chine] ; Jia-Yih Feng [République populaire de Chine] ; Hsiang-Ling Ho [République populaire de Chine] ; Yi-Tsung Lin [République populaire de Chine] ; Su-Jung Chen [République populaire de Chine] ; Shiang-Fen Huang [République populaire de Chine] ; Hsin-Pai Chen [République populaire de Chine] ; Teh-Ying Chou [République populaire de Chine] ; Yuh-Min Chen [République populaire de Chine] ; Fu-Der Wang [République populaire de Chine]The clinical manifestations and interval changes of reverse-transcriptase quantitative polymerase chain reactions among different specimens of coronavirus disease 2019 patients.
000109 (2021) Hailey Olds [États-Unis] ; Jesse Liu [États-Unis] ; Kevin Luk [États-Unis] ; Henry W. Lim [États-Unis] ; David Ozog [États-Unis] ; Pranita V. Rambhatla [États-Unis]Telogen effluvium associated with COVID-19 infection.
000114 (2021) Viveksandeep Thoguluva Chandrasekar [États-Unis] ; Bhanuprasad Venkatesalu [États-Unis] ; Harsh K. Patel [États-Unis] ; Marco Spadaccini [Italie] ; Jacob Manteuffel [États-Unis] ; Mayur Ramesh [États-Unis]Systematic review and meta-analysis of effectiveness of treatment options against SARS-CoV-2 infection.
000118 (2021) Carlo Salvarani [Italie] ; Pamela Mancuso [Italie] ; Federica Gradellini [Italie] ; Nilla Viani [Italie] ; Paolo Pandolfi [Italie] ; Massimo Reta [Italie] ; Giuliano Carrozzi [Italie] ; Gilda Sandri [Italie] ; Gianluigi Bajocchi [Italie] ; Elena Galli [Italie] ; Francesco Muratore [Italie] ; Luigi Boiardi [Italie] ; Nicol Pipitone [Italie] ; Giulia Cassone [Italie] ; Stefania Croci [Italie] ; Anna Maria Marata [Italie] ; Massimo Costantini [Italie] ; Paolo Giorgi Rossi [Italie]Susceptibility to COVID-19 in Patients Treated With Antimalarials: A Population-Based Study in Emilia-Romagna, Northern Italy.
000120 (2021) Giancarlo Ceccarelli [Italie] ; Francesco Alessandri [Italie] ; Alessandra Oliva [Italie] ; Serena Dell'Isola [Italie] ; Monica Rocco [Italie] ; Franco Ruberto [Italie] ; Francesco Pugliese [Italie] ; Gabriella D'Ettorre [Italie] ; Mario Venditti [Italie]Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent.
000122 (2021) Caterina Giannitto [Italie] ; Cristiana Bonifacio [Italie] ; Susanna Esposito [Italie] ; Angela Ammirabile [Italie] ; Giuseppe Mercante [Italie] ; Armando De Virgilio [Italie] ; Giuseppe Spriano [Italie] ; Enrico Heffler [Italie] ; Ludovica Lofino [Italie] ; Letterio Salvatore Politi [Italie] ; Luca Balzarini [Italie]Sudden neck swelling with rash as late manifestation of COVID-19: a case report.
000124 (2021) Chun-Chou Tsai [Taïwan] ; Yung-Chih Wang [Taïwan] ; Tsung-Ta Chiang [Taïwan] ; I-An Chen [Taïwan] ; Chun-Hsiang Chiu [Taïwan] ; Ya-Sung Yang [Taïwan] ; Kuo-Ming Yeh [Taïwan] ; Feng-Yee Chang [Taïwan]Successful treatment of 28 patients with coronavirus disease 2019 at a medical center in Taiwan.
000133 (2021) Isidro García-Meni O [Espagne] ; Lorena Forcelledo [Espagne] ; Yaiza Rosete [Espagne] ; Emilio García-Prieto [Espagne] ; Dolores Escudero [Espagne] ; Javier Fernández [Espagne]Spread of OXA-48-producing Klebsiella pneumoniae among COVID-19-infected patients: The storm after the storm.
000134 (2021) Fatemeh Roozbeh [Iran] ; Majid Saeedi [Iran] ; Reza Alizadeh-Navaei [Iran] ; Akbar Hedayatizadeh-Omran [Iran] ; Shahin Merat [Iran] ; Hannah Wentzel [Royaume-Uni] ; Jacob Levi [Royaume-Uni] ; Andrew Hill [Royaume-Uni] ; Amir Shamshirian [Iran]Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial.
000135 (2021) Baptiste Maille [France] ; Marie Wilkin [France] ; Matthieu Million [France] ; Noémie Rességuier [France] ; Frédéric Franceschi [France] ; Linda Koutbi-Franceschi [France] ; Jérôme Hourdain [France] ; Elisa Martinez [France] ; Maxime Zabern [France] ; Christophe Gardella [France] ; Hervé Tissot-Dupont [France] ; Jagmeet P. Singh [États-Unis] ; Jean-Claude Deharo [France] ; Laurent Fiorina [France]Smartwatch Electrocardiogram and Artificial Intelligence for Assessing Cardiac-Rhythm Safety of Drug Therapy in the COVID-19 Pandemic. The QT-logs study.
000136 (2021) T Y Andy Ko [Malaisie] ; L S Chen [Malaisie] ; I X Pang [Malaisie] ; H S Ling [Malaisie] ; T C Wong [Malaisie] ; L L Sia Tonnii [Malaisie] ; K T Koh [Malaisie]Smartphone electrocardiogram for QT interval monitoring in Coronavirus Disease 2019 (COVID-19) patients treated with Hydroxychloroquine.
000140 (2021) Juan Macías [Espagne] ; Paz González-Moreno [Espagne] ; Esther Sánchez-García [Espagne] ; Ram N Morillo-Verdugo [Espagne] ; José J. Pérez-Venegas [Espagne] ; Ana Pinilla [Espagne] ; M Mar Macho [Espagne] ; M Victoria Martínez [Espagne] ; Alejandro González-Serna [Espagne] ; Anaïs Corma [Espagne] ; Luis M. Real [Espagne] ; Juan A. Pineda [Espagne]Similar incidence of coronavirus disease 2019 (COVID-19) in patients with rheumatic diseases with and without hydroxychloroquine therapy.
000141 (2021) Zhi-Yuan Pan [République populaire de Chine] ; Yu-Xiao Chang [République populaire de Chine] ; Ni Han [République populaire de Chine] ; Feng-Yi Hou [République populaire de Chine] ; B J Yang Lee [République populaire de Chine] ; Fa-Chao Zhi [République populaire de Chine] ; Rui-Fu Yang [République populaire de Chine] ; Yu-Jing Bi [République populaire de Chine]Short-term high-dose gavage of hydroxychloroquine changes gut microbiota but not the intestinal integrity and immunological responses in mice.
000142 (2021) Mohamed S. Mohamed [Suède] ; Thiago C. Moulin [Suède] ; Helgi B. Schiöth [Suède, Russie]Sex differences in COVID-19: the role of androgens in disease severity and progression.
000144 (2021) Rajesh Kulkarni [Inde] ; Uday Rajput [Inde] ; Rahul Dawre [Inde] ; Naresh Sonkawade [Inde] ; Sameer Pawar [Inde] ; Somendra Sonteke [Inde] ; Balaji Varvatte [Inde] ; K C Aathira [Inde] ; Kailas Gadekar [Inde] ; Santosh Varma [Inde] ; Leena Nakate [Inde] ; Anju Kagal [Inde] ; Aarti Kinikar [Inde]Severe Malnutrition and Anemia Are Associated with Severe COVID in Infants.
000153 (2021) Kavita Manchanda [Inde] ; Jasbir Singh [Inde] ; Ranjeev Bhagat [Inde] ; Ilmjot Kaur Tiwana [Inde] ; Harmanjit Singh [Inde]Safety of pharmacological options for the management of COVID-19 in pregnant women: An Indian perspective.
000157 (2021) Ozgur Sogut [Turquie] ; Mehmet Mustafa Can [Turquie] ; Ramazan Guven [Turquie] ; Onur Kaplan [Turquie] ; Hüseyin Ergenc [Turquie] ; Tuba Betül Umit [Turquie] ; Olgun Demir [Turquie] ; Murat Kaya [Turquie] ; Tar K Akdemir [Turquie] ; Sümeyye Cakmak [Turquie]Safety and efficacy of hydroxychloroquine in 152 outpatients with confirmed COVID-19: A pilot observational study.
000158 (2021) Hany M. Dabbous [Égypte] ; Manal H. El-Sayed [Égypte] ; Gihan El Assal [Égypte] ; Hesham Elghazaly [Égypte] ; Fatma F S. Ebeid [Égypte] ; Ahmed F. Sherief [Égypte] ; Maha Elgaafary [Égypte] ; Ehab Fawzy [Égypte] ; Sahar M. Hassany [Égypte] ; Ahmed R. Riad [Égypte] ; Mohamed A. Tageldin [Égypte]Safety and efficacy of favipiravir versus hydroxychloroquine in management of COVID-19: A randomised controlled trial.
000160 (2021) Saeidreza Jamalimoghadamsiahkali [Iran] ; Besharat Zarezade [Iran] ; Sogol Koolaji [Iran] ; Seyedahmad Seyedalinaghi [Iran] ; Abolfazl Zendehdel [Iran] ; Mohammad Tabarestani [Iran] ; Ehsan Sekhavati Moghadam [Iran] ; Ladan Abbasian [Iran] ; Seyed Ali Dehghan Manshadi [Iran] ; Mohamadreza Salehi [Iran] ; Malihe Hasannezhad [Iran] ; Sara Ghaderkhani [Iran] ; Mohsen Meidani [Iran] ; Faeze Salahshour [Iran] ; Fatemeh Jafari [Iran] ; Navid Manafi [Canada] ; Fereshteh Ghiasvand [Iran]Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial.
000165 (2021) Pablo Chicharro [Espagne] ; Pedro Rodríguez-Jiménez [Espagne] ; Ester Mu Oz-Aceituno [Espagne] ; Diego De Argila [Espagne] ; Patricia Mu Oz-Hernández [Espagne] ; Mar Llamas-Velasco [Espagne]SDRIFE-like rash associated with COVID-19, clinicopathological correlation.
000167 (2021) Masoomeh Sofian [Iran] ; Ali Akbar Velayati [Iran] ; Mohammad Banifazl [Iran] ; Fatemeh Fotouhi [Iran] ; Mona Sadat Larijani [Iran] ; Neda Afzali [Iran] ; Amitis Ramezani [Iran]SARS-CoV‑2, a virus with many faces: a series of cases with prolonged persistence of COVID-19 symptoms.
000170 (2021) Filipa Silva [Portugal] ; Ana Cipriano [Portugal] ; Hugo Cruz [Portugal] ; Joana Tavares [Portugal] ; Joana Fragoso [Portugal] ; Jorge Malheiro [Portugal] ; Manuela Almeida [Portugal] ; La Salete Martins [Portugal] ; Miguel Abreu [Portugal] ; Sofia Pedroso [Portugal] ; Leonídio Dias [Portugal] ; Ant Nio Castro Henriques [Portugal]SARS-CoV-2 infection in kidney transplant recipients: Early report of five cases.
000177 (2021) Kevin L. Winthrop [États-Unis] ; Amanda E. Brunton [États-Unis] ; Susan Beekmann [États-Unis] ; Philip Polgreen [États-Unis] ; John Baddley [États-Unis] ; Kenneth G. Saag [États-Unis] ; Cassandra Calabrese [États-Unis] ; Leonard Calabrese [États-Unis] ; Philip C. Robinson [Australie] ; Zachary S. Wallace [États-Unis] ; Jeffrey R. Curtis [États-Unis]SARS CoV-2 infection among patients using immunomodulatory therapies.
000179 (2021) Priyamadhaba Behera [Inde] ; Binod Kumar Patro [Inde] ; Arvind Kumar Singh [Inde] ; Pradnya Dilip Chandanshive [Inde] ; Ravikumar S R [Inde] ; Somen Kumar Pradhan [Inde] ; Siva Santosh Kumar Pentapati [Inde] ; Gitanjali Batmanabane [Inde] ; Prasanta Raghab Mohapatra [Inde] ; Biswa Mohan Padhy [Inde] ; Shakti Kumar Bal [Inde] ; Sudipta Ranjan Singh [Inde] ; Rashmi Ranjan Mohanty [Inde]Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study.
000180 (2021) Ilad Alavi Darazam [Iran] ; Shervin Shokouhi [Iran] ; Mohamad Amin Pourhoseingholi [Iran] ; Seyed Sina Naghibi Irvani [Iran] ; Majid Mokhtari [Iran] ; Minoosh Shabani [Iran] ; Mahdi Amirdosara [Iran] ; Parham Torabinavid [Iran] ; Maryam Golmohammadi [Iran] ; Sayedpayam Hashemi [Iran] ; Arsalan Azimi [Iran] ; Mohammad Hossein Jafarazadeh Maivan [Iran] ; Omidvar Rezaei [Iran] ; Alireza Zali [Iran] ; Mohammadreza Hajiesmaeili [Iran] ; Hadiseh Shabanpour Dehbsneh [Iran] ; Akram Hoseyni Kusha [Iran] ; Maryam Taleb Shoushtari [Iran] ; Negar Khalili [Iran] ; Azam Soleymaninia [Iran] ; Latif Gachkar [Iran] ; Ali Khoshkar [Iran]Role of interferon therapy in severe COVID-19: the COVIFERON randomized controlled trial.
000185 (2021) Sonsoles Salto-Alejandre [Espagne] ; Silvia Jiménez-Jorge [Espagne] ; Nuria Sabé [Espagne] ; Antonio Ramos-Martínez [Espagne] ; Laura Linares [Espagne] ; Maricela Valerio [Espagne] ; Pilar Martín-Dávila [Espagne] ; Mario Fernández-Ruiz [Espagne] ; María Carmen Fari As [Espagne] ; Marino Blanes-Juliá [Espagne] ; Elisa Vidal [Espagne] ; Zaira R. Palacios-Baena [Espagne] ; Román Hernández-Gallego [Espagne] ; Jordi Carratalá [Espagne] ; Jorge Calder N-Parra [Espagne] ; María Ángeles Marcos [Espagne] ; Patricia Mu Oz [Espagne] ; Jesús Fortún-Abete [Espagne] ; José María Aguado [Espagne] ; Francisco Arnaiz-Revillas [Espagne] ; Rosa Blanes-Hernández [Espagne] ; Julián De La Torre-Cisneros [Espagne] ; Luis E. L Pez-Cortés [Espagne] ; Elena García De Vinuesa-Calvo [Espagne] ; Clara M. Rosso [Espagne] ; Jer Nimo Pach N [Espagne] ; Javier Sánchez-Céspedes [Espagne] ; Elisa Cordero [Espagne]Risk factors for unfavorable outcome and impact of early post-transplant infection in solid organ recipients with COVID-19: A prospective multicenter cohort study.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidChloroV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Female (MeSH)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Female (MeSH)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidChloroV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Female (MeSH)
}}

Wicri

This area was generated with Dilib version V0.6.38.
Data generation: Sat May 22 17:02:32 2021. Site generation: Sat May 22 17:06:52 2021